UCLA Health found that common long-term residential exposure to chlorpyrifos was associated with more than a 2.5-fold increase in Parkinson's disease risk. The work, published in Molecular Neurodegeneration, paired California pesticide use records with residential and workplace addresses to estimate exposure.
UCLA Health Parkinson's study
The analysis covered 829 people diagnosed with Parkinson's disease and 824 individuals without the condition, all enrolled in UCLA's ongoing Parkinson's Environment and Genes study. Researchers used those records to compare people living near treated areas with others in the same study group, giving the report a direct residential measure rather than a broad county-level estimate.
The laboratory work followed the human analysis. Mice exposed to aerosolized chlorpyrifos for 11 weeks developed movement problems, lost dopamine-producing neurons, showed signs of brain inflammation, and developed an abnormal buildup of alpha-synuclein. Those findings line up with the study's human result by pointing to damage in the same brain systems that Parkinson's disease affects.
Chlorpyrifos rules in 2001 and 2021
The timing adds friction to the result. Residential uses of chlorpyrifos were banned in 2001, and agricultural applications faced restrictions in 2021, yet chlorpyrifos has been used on agricultural crops for decades and remains common in many other countries. The study's risk estimate therefore concerns a substance that is no longer allowed in homes but still appears in crop use patterns that can shape long-term exposure near where people live and work.
For readers living near treated fields, the practical takeaway is narrow but important: the study links long-term residential exposure with higher risk, not a one-time encounter. It does not offer a medical remedy or a new rule, so the most immediate value is in understanding exposure history and how a pesticide still in use on crops can align with later neurological harm.
Parkinson's disease and alpha-synuclein
Parkinson's disease affects nearly one million Americans and develops as dopamine-producing brain cells gradually die off. The new report adds a quantified human association and a matching lab signal in zebrafish-related research context through alpha-synuclein work, but the published facts here stop short of separating chlorpyrifos from every other environmental or genetic factor that may contribute to a person's overall risk.
The remaining question is how much of the reported increase comes from chlorpyrifos exposure alone and how much reflects other factors tracked in UCLA's Environment and Genes work. For now, the strongest reading is simple: the common pesticide is still part of the exposure picture, and this study ties that picture to a higher Parkinson's disease risk.
